Patent details

EP4375659 Title: A METHOD FOR THE QUANTITATIVE DETERMINATION OF HUMAN SERUM ALBUMIN MONOMER IN VIRUS-CONTAINING PHARMACEUTICAL COMPOSITIONS

Basic Information

Publication number:
EP4375659
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP232127035
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A METHOD FOR THE QUANTITATIVE DETERMINATION OF HUMAN SERUM ALBUMIN MONOMER IN VIRUS-CONTAINING PHARMACEUTICAL COMPOSITIONS
French Title of Invention:
PROCÉDÉ POUR LA DÉTERMINATION QUANTITATIVE DE MONOMÈRES D'ALBUMINE SÉRIQUE HUMAINE DANS DES COMPOSITIONS PHARMACEUTIQUES CONTENANT DES VIRUS
German Title of Invention:
VERFAHREN ZUR QUANTITATIVEN BESTIMMUNG VON MENSCHLICHEM SERUMALBUMINMONOMER IN VIRUSHALTIGEN PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
10/04/2025
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
17/04/2025
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
26/03/2025
Unitary Effect Registration Date:
17/04/2025
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
28/11/2023
Grant date:
26/03/2025
EP Publication Date:
29/05/2024
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/03/2025
EP B1 Publication Date:
26/03/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/11/2043
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/03/2025
 
 

Name:
Takeda Vaccines, Inc.
Address:
75 Sidney Street, Cambridge, MA 02139, United States (US)

Inventor

Name:
SOMANADHAN, Brinda
Address:
United States (US)

Priority

Priority Number:
22210027
Priority Date:
28/11/2022
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
G01N 30/88;

Publication

European Patent Bulletin

1

Issue number:
202513
Publication date:
26/03/2025
Description:
Grant (B1)

2

Issue number:
202521
Publication date:
21/05/2025
Description:
Unitary Effect Request Receipt

3

Issue number:
202521
Publication date:
21/05/2025
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages